At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02185 BIOHEART-B
Closed 12-19 16:05:14
5.790
+0.190
+3.39%
High5.870
Low5.600
Vol176.70K
Open5.600
D1 Closing5.600
Amplitude4.82%
Mkt Cap1.41B
Tradable Cap1.36B
Total Shares243.42M
T/O1.02M
T/O Rate0.07%
Tradable Shares235.70M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Wang Philip Li Increases Stake in BIOHEART-B (02185) by 10,000 Shares at HK$5.656 per Share
Shanghai Bio-heart Biological Technology Co Ltd is a China-based company mainly engaged in the business of interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products comprise fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension. The Company's products are used in addressing the unmet medical needs of Chinese patients for the treatment of coronary artery diseases and the unmet medical needs of patients for the treatment of uncontrolled hypertension. The Company mainly conducts its businesses in the domestic market and overseas markets.